Clinical Trials Directory

Trials / Completed

CompletedNCT01321671

Investigation Of Absorption And Pharmacokinetics Of A Single Dose Of Controlled Release Pregabalin Tablet Administered Fasted In The Evening or Immediately Following A 600-750 Calorie Evening Meal As Compared To Single Dose Of Immediate Release Pregabalin Capsule In Healthy Volunteers

The Pharmacokinetics Of Pregabalin Controlled Release Formulation In Fed State Compared To The Controlled Release And Immediate Release Formulations In The Fasted State

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the pharmacokinetics of a single dose of a pregabalin controlled release (CR) tablet administered fasted in the evening relative to a single dose of the CR tablet administered immediately following a 600 to 750 calorie evening meal. The single dose pharmacokinetics of the pregabalin CR administered fed or fasted will also be compared to the single dose pharmacokinetics of the pregabalin immediate release (IR) capsule. In addition, the safety and tolerability of these 3 treatments will be evaluated.

Detailed description

Evaluate the absorption, pharmacokinetics, safety/tolerability of a single dose of a pregabalin CR tablet under various conditions as compared to single dose of pregabalin IR capsule

Conditions

Interventions

TypeNameDescription
DRUGPregabalin controlled release, 330 mg, 600- 750 calorieA single oral dose of 330 mg controlled release tablet administered following a 600 to 750 calorie evening meal
DRUGPregabalin controlled release, 330 mg, fastedA single oral dose of 330 mg controlled release tablet administered fasted in the evening
DRUGPregabalin immediate release, 300 mgA single oral dose of 300 mg immediate release capsule administered in the evening

Timeline

Start date
2011-04-01
Primary completion
2011-06-01
Completion
2011-06-01
First posted
2011-03-23
Last updated
2021-01-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01321671. Inclusion in this directory is not an endorsement.

Investigation Of Absorption And Pharmacokinetics Of A Single Dose Of Controlled Release Pregabalin Tablet Administered F (NCT01321671) · Clinical Trials Directory